Wound and Tissue Management Market Size, Share, and COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Wound Closure Market, Anti-adhesion Market, and 11 more
- Year: 2022
- Scope: 10 Years
- Region: United States
- Pages: 499
- Published Date: 03/11/2022
- Type: MedSuite
In 2021, the U.S. wound and tissue management market size was valued at $10.7 billion. The total market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to exceed $13.8 billion by 2028.
The full report suite on the U.S. market for wound and tissue management includes wound closure devices, traditional, moist, antimicrobial and interactive wound dressings, non-adherent contact layers, surgical hemostats, tissue sealants, anti-adhesion, negative pressure wound therapy and static and dynamic compression therapy.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2028, and Historical Data to 2018
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Procedure Volumes
- Company Profiles, Product Portfolios and SWOT for Top Competitors
- COVID-19 Impact Analysis
U.S. WOUND AND TISSUE MANAGEMENT MARKET TRENDS
There are many factors underpinning the growth of the U.S. wound and tissue management market. A primary growth factor is the demographic structure of the population. As of 2021, 16.9% of the population is aged 65 or older. This figure is expected to reach approximately 20% by 2028. It is estimated that 3-6% of this population will suffer from venous leg ulcers. Treatment costs for these individuals will further contribute to an already significant healthcare market in the United States.
U.S. WOUND AND TISSUE MANAGEMENT MARKET SHARE INSIGHTS
Overall, within the U.S. wound and tissue management market there are three dominant competitors: Ethicon, 3M and Medtronic.
In 2021, the leading competitor in the wound and tissue management market was Ethicon. Ethicon has a wide array of products generally priced on the higher end of the market. However, the company’s portfolio offers a competitive advantage because it can bundle its well-known brand names with discounts.
MARKET SEGMENTATION SUMMARY
While this report suite contains all U.S. wound and tissue management device data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the wound and tissue management market research that you need. You can view all these included reports and segmentation here:
- U.S. Market Report for Wound Closure – MedCore – This market includes sutures, staplers, ligating clip appliers, skin closure strips, mesh and cyanoacrylate-based skin closure systems, zip surgical skin closure systems and cyanoacrylate-based tissue adhesives.
- U.S. Market Report for Traditional Wound Dressings – MedCore – The U.S. traditional dressing market includes gauze, tapes, bandages (excluding compression bandages) and cotton products.
- U.S. Market Report for Advanced Wound Dressings – MedCore – The market includes moist dressings, antimicrobial dressings, interactive dressings and non-adherent contact layers.
- U.S. Market Report for Moist Dressings – MedCore – The market is segmented into foam, transparent film, hydrocolloid, alginate, gelling fiber and hydrogel dressings.
- U.S. Market Report for Antimicrobial Dressings – MedCore – This market includes silver and non-silver dressings with antimicrobial properties, with the silver dressing market accounting for almost two thirds of the market.
- U.S. Market Report for Interactive Dressings – MedCore – This market includes biomaterials (collagen and combinations based on collagen as a carrier, except silver) and skin substitutes.
- U.S. Market Report for Non-Adherent Contact Layers – MedCore – Contact layers are designed for a variety of wounds including skin tears and abrasions, surgical incisions, second degree burns, blisters, grafts, diabetic ulcers and venous leg ulcers
- U.S. Market Report for Surgical Hemostats – MedCore – This market includes both passive and active hemostats. Active hemostats include thrombin-based, combination and polysaccharide-based hemostats, while passive hemostats comprise oxidized regenerated cellulose (ORC), gelatin-based, collagen-based and first responder hemostats.
- U.S. Market Report for Tissue Sealants – MedCore – The market is segmented into fibrin-based, protein-based and synthetic tissue sealants, with fibrin and synthetic tissue sealants being the most prevalent.
- U.S. Market Report for Anti-Adhesion – MedCore – This market includes anti-adhesion dressings used for gynecological, abdominal and other procedures.
- U.S. Market Report for Negative Pressure Wound Therapy – MedCore – This market contains markets for Single-Use Pumps, Conventional NPWT Pump Rentals, Canisters and NPWT Dressings.
- U.S. Market Report for Static Compression Therapy – MedCore – The U.S. market for static compression therapy includes graduated compression stockings, anti-embolism stockings, compression bandages and Unna boots.
- U.S. Market Report for Dynamic Compression Therapy – MedCore – The market is segmented into dynamic DVT prevention sleeves, mobile DVT prevention and pneumatic compression.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | United States |
| Base Year | 2021 |
| Forecast | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
Table of Contents
| TABLE of CONTENTS |
| List of Figures |
| List of Charts |
| executive summary |
| U.S. Wound and Tissue Management Market Overview |
| Competitive Analysis |
| Market Trends |
| Market Developments |
| Markets Included |
| Key Report Updates |
| Version History |
| research methodology |
| Step 1: Project Initiation & Team Selection |
| Step 2: Prepare Data Systems and Perform Secondary Research |
| Step 3: Preparation for Interviews & Questionnaire Design |
| Step 4: Performing Primary Research |
| Step 5: Research Analysis: Establishing Baseline Estimates |
| Step 6: Market Forecast and Analysis |
| Step 7: Identify Strategic Opportunities |
| Step 8: Final Review and Market Release |
| Step 9: Customer Feedback and Market Monitoring |
| impact of covid-19 on THE U.S. Wound and Tissue Management Market |
| 2.1 Introduction |
| 2.2 Analysis By Market Segment |
| 2.2.1 Worst Case Scenario |
| 2.2.2 Base Case Scenario |
| 2.2.3 Best Case Scenario |
| Disease Overview |
| 3.1 Disease Treatment and Diagnostic |
| 3.1.1 Vascular Malformations |
| 3.1.2 Deep Ven Thrombosis and Pulmonary Embolism |
| 3.1.3 Lower Extremity Ulcers |
| 3.1.4 Lymphedema |
| 3.1.5 Surgery |
| 3.1.6 Traumas and Burns |
| 3.2 Patient Demographics |
| 3.2.1 Vascular Malformations |
| 3.2.2 Deep Vein Thrombosis and Pulmonary Embolism |
| 3.2.3 Lower Extremity Ulcers |
| 3.2.4 Lymphedema |
| 3.2.5 Traumas and Burns |
| Product Assessment |
| 4.1 Introduction |
| 4.2 Product Portfolios |
| 4.2.1 Wound Closure Devices |
| 4.2.1.1 Sutures |
| 4.2.1.2 Staplers |
| 4.2.1.3 Ligating Clip Appliers |
| 4.2.1.4 Wound Closure Strips |
| 4.2.1.5 Tissue Adhesives |
| 4.2.2 Traditional Wound Dressings |
| 4.2.3 Advanced Wound Dressings |
| 4.2.3.1 Moist Dressings |
| 4.2.3.1.1 Foam Dressings |
| 4.2.3.1.2 Transparent Film Dressings |
| 4.2.3.1.3 Hydrocolloid Dressings |
| 4.2.3.1.4 Alginate Dressings |
| 4.2.3.1.5 Gelling Fiber Dressings |
| 4.2.3.1.6 Hydrogel Dressings |
| 4.2.3.2 Antimicrobial Dressings |
| 4.2.3.2.1 Silver Dressing |
| 4.2.3.2.2 Non-Silver Dressing |
| 4.2.3.3 Interactive Dressing |
| 4.2.3.3.1 Bioactive Dressings |
| 4.2.3.3.2 Skin Substitute |
| 4.2.3.4 Non-Adherent Contact Layer |
| 4.2.3.5 Super Absorbent Wound Dressings |
| 4.2.4 Surgical Hemostats |
| 4.2.4.1 Thrombin-Based Hemostats |
| 4.2.4.2 Oxidized Regenerated Cellulose Hemostats |
| 4.2.4.3 Gelatin-Based Hemostat |
| 4.2.4.4 Collagen-Based Hemostat |
| 4.2.4.5 Combination Hemostat |
| 4.2.4.6 Polysaccharide-Based Hemostat |
| 4.2.4.7 First Responder Hemostat |
| 4.2.5 Tissue Sealants |
| 4.2.5.1 Fibrin-Based Tissue Sealants |
| 4.2.5.2 Albumin-Based Tissue Sealants |
| 4.2.5.3 Synthetic Tissue Sealants |
| 4.2.6 Anti-Adhesion |
| 4.2.7 Negative Pressure Wound Therapy |
| 4.2.8 Static Compression Therapy |
| 4.2.8.1 Compression Stockings |
| 4.2.8.2 Anti-Embolism Stockings |
| 4.2.8.3 Compression Bandages |
| 4.2.8.4 Unna Boots |
| 4.2.9 Dynamic Compression Therapy |
| 4.2.9.1 Dynamic DVT Prevention |
| 4.2.9.2 Mobile DVT Prevention |
| 4.2.9.3 Pneumatic Compression |
| 4.3 Regulatory Issues and Recalls |
| 4.3.1 Ethicon |
| 4.3.1.1 Wound Closure Market |
| 4.3.2 Medtronic |
| 4.3.2.1 Wound Closure Market |
| 4.4 Clinical Trials |
| 4.4.1 3M |
| 4.4.1.1 Wound Closure Devices |
| 4.4.2 Acelity |
| 4.4.2.1 Negative Pressure Wound Therapy |
| 4.4.3 Cardinal Health |
| 4.4.3.1 Negative Pressure Wound Therapy |
| 4.4.4 Ethicon |
| 4.4.4.1 Wound Closure Devices |
| 4.4.5 Molnlycke |
| 4.4.5.1 Advanced Wound Dressings |
| 4.4.6 Smith and Nephew |
| 4.4.6.1 Negative Pressure Wound Therapy |
| U.S. Wound and Tissue Management Market Overview |
| 5.1 Introduction |
| 5.2 Market Overview & Trend Analysis |
| 5.3 Drivers and Limiters |
| 5.3.1 Market Drivers |
| 5.3.2 Market Limiters |
| 5.4 Competitive Market Share Analysis |
| 5.5 Mergers and Acquisitions |
| 5.6 Company Profiles |
| 5.6.1 3M |
| 5.6.1.1 Acelity |
| 5.6.2 Baxter |
| 5.6.3 Essity |
| 5.6.4 Becton Dickinson |
| 5.6.5 Cardinal Health |
| 5.6.6 CryoLife |
| 5.6.7 Ethicon |
| 5.6.8 Medline |
| 5.6.9 Medtronic |
| 5.6.10 MiMedx |
| 5.6.11 Mölnlycke |
| 5.6.12 Pfizer |
| 5.6.13 Smith & Nephew |
| 5.7 SWOT Analysis |
| 5.7.1 3M |
| 5.7.2 Baxter |
| 5.7.3 Essity |
| 5.7.4 Becton Dickinson |
| 5.7.5 Cardinal Health |
| 5.7.6 Cryolife |
| 5.7.7 Ethicon |
| 5.7.8 Medline |
| 5.7.9 Medtronic |
| 5.7.10 MiMedx |
| 5.7.11 Mölnlycke |
| 5.7.12 Pfizer |
| 5.7.13 Smith & Nephew |
| Wound Closure Market |
| 6.1 Introduction |
| 6.1.1 Sutures |
| 6.1.2 Staplers |
| 6.1.3 Ligating Clip Appliers |
| 6.1.4 Skin Closure Strips |
| 6.1.5 Mesh and Cyanoacrylate-Based Skin Closure System |
| 6.1.6 Zip Surgical Skin Closure |
| 6.1.7 Cyanoacrylate-Based Tissue Adhesives |
| 6.2 Market Overview |
| 6.3 Market Analysis and Forecast |
| 6.3.1 Suture Market |
| 6.3.1.1 Suture Market by Device Type |
| 6.3.1.1.1 Absorbable Suture Market |
| 6.3.1.1.2 Non-Absorbable Suture Market |
| 6.3.1.1.3 Knotless Tissue Closure Market |
| 6.3.1.2 Suture Market by Infection Control Type |
| 6.3.1.2.1 Antibacterial Suture Market |
| 6.3.1.2.2 Standard Suture Market |
| 6.3.1.3 Suture Market by Care Setting |
| 6.3.1.3.1 Hospital Suture Market |
| 6.3.1.3.2 Alternate Care Suture Market |
| 6.3.2 Stapler Market |
| 6.3.2.1 Stapler Market by Device Type |
| 6.3.2.1.1 Open Surgery Stapler Market |
| 6.3.2.1.2 Laparoscopic Stapler Market |
| 6.3.2.1.3 Skin Stapler Market |
| 6.3.2.2 Stapler Market by Care Setting |
| 6.3.2.2.1 Hospital Stapler Market |
| 6.3.2.2.2 Alternate Care Stapler Market |
| 6.3.3 Ligation Clip Applier Market |
| 6.3.3.1 Ligating Clip Applier Market by Device Type |
| 6.3.3.1.1 Open Surgery Ligation Market |
| 6.3.3.1.2 Laparoscopic Ligation Market |
| 6.3.3.2 Ligation Market by Care Setting |
| 6.3.3.2.1 Hospital Ligation Market |
| 6.3.3.2.2 Alternate Care Ligation Market |
| 6.3.4 Skin Closure Strip Market |
| 6.3.4.1 Hospital Skin Closure Strip Market |
| 6.3.4.2 Alternate Care Skin Closure Strip Market |
| 6.3.5 Mesh and Cyanoacrylate-Based Skin Closure System Market |
| 6.3.6 Zip Surgical Skin Closure Market |
| 6.3.7 Cyanoacrylate-Based Tissue Adhesive Market |
| 6.3.7.1 Hospital Cyanoacrylate-Based Tissue Adhesive Market |
| 6.3.7.2 Alternate Care Cyanoacrylate-Based Tissue Adhesive Market |
| 6.4 Drivers and Limiters |
| 6.4.1 Market Drivers |
| 6.4.2 Market Limiters |
| 6.5 Competitive Market Share Analysis |
| Traditional Wound Dressing Market |
| 7.1 Introduction |
| 7.2 Market Overview |
| 7.3 Market Analysis and Forecast |
| 7.3.1 Gauze Market |
| 7.3.1.1 Hospital Gauze Market |
| 7.3.1.2 Alternate Care Gauze Market |
| 7.3.2 Tape Market |
| 7.3.2.1 Hospital Tape Market |
| 7.3.2.2 Alternate Care Tape Market |
| 7.3.3 Bandage Market |
| 7.3.3.1 Hospital Bandage Market |
| 7.3.3.2 Alternate Care Bandage Market |
| 7.3.4 Cotton Market |
| 7.3.4.1 Hospital Cotton Market |
| 7.3.4.2 Alternate Care Cotton Market |
| 7.4 Drivers and Limiters |
| 7.4.1 Market Drivers |
| 7.4.2 Market Limiters |
| 7.5 Competitive Market Share Analysis |
| Advanced Wound Dressing Market Overview |
| 8.1 Introduction |
| 8.1.1 Moist Advanced Dressings |
| 8.1.2 Antimicrobial Advanced Dressings |
| 8.1.3 Interactive Advanced Dressings |
| 8.1.4 Non-Adherent Contact Layers |
| 8.2 Market Overview |
| 8.3 Drivers and Limiters |
| 8.3.1 Market Drivers |
| 8.3.2 Market Limiters |
| 8.4 Competitive Market Share Analysis |
| Moist Dressing Market |
| 9.1 Introduction |
| 9.1.1 Foam Dressings |
| 9.1.2 Transparent Film Dressings |
| 9.1.3 Hydrocolloid Dressings |
| 9.1.4 Alginate Dressings |
| 9.1.5 Gelling Fiber Dressings |
| 9.1.6 Hydrogel Dressings |
| 9.2 Market Overview |
| 9.2.1 Moist Dressing Market by Segment |
| 9.2.2 Moist Dressing Market by Care Setting |
| 9.3 Market Analysis and Forecast |
| 9.3.1 Moist Dressing Market |
| 9.3.2 Foam Dressing Market |
| 9.3.3 Transparent Film Dressing Market |
| 9.3.4 Hydrocolloid Dressing Market |
| 9.3.5 Alginate Dressing Market |
| 9.3.6 Gelling Fiber Dressing Market |
| 9.3.7 Hydrogel Dressing Market |
| 9.3.8 Hospital Moist Dressing Market |
| 9.3.9 Alternate Care Moist Dressing Market |
| 9.4 Drivers and Limiters |
| 9.4.1 Market Drivers |
| 9.4.2 Market Limiters |
| 9.5 Competitive Market Share Analysis |
| Antimicrobial Dressing Market |
| 10.1 Introduction |
| 10.1.1 Silver Dressings |
| 10.1.2 Non-Silver Dressings |
| 10.2 Market Overview |
| 10.2.1 Antimicrobial Dressing Market by Segment |
| 10.2.2 Antimicrobial Dressing Market by Care Setting |
| 10.3 Market Analysis and Forecast |
| 10.3.1 Antimicrobial Dressing Market |
| 10.3.2 Silver Dressing Market |
| 10.3.3 Non-Silver Dressing Market |
| 10.3.4 Hospital Antimicrobial Dressing Market |
| 10.3.5 Alternate Care Antimicrobial Dressing Market |
| 10.4 Drivers and Limiters |
| 10.4.1 Market Drivers |
| 10.4.2 Market Limiters |
| 10.5 Competitive Market Share Analysis |
| Interactive Dressing Market |
| 11.1 Introduction |
| 11.1.1 Biomaterials |
| 11.1.2 Skin Substitutes |
| 11.2 Market Overview |
| 11.2.1 Interactive Dressing Market by Segment |
| 11.3 Market Analysis and Forecast |
| 11.3.1 Collagen Dressing Market |
| 11.3.2 Skin Substitute Market |
| 11.3.2.1 Particulate Skin Substitute Market |
| 11.3.2.2 Sheet Skin Substitute Market |
| 11.3.2.3 Other Substitute Market |
| 11.3.3 Hospital Skin Substitute Market |
| 11.3.4 Alternate Care Skin Substitute Market |
| 11.4 Drivers and Limiters |
| 11.4.1 Market Drivers |
| 11.4.2 Market Limiters |
| 11.5 Competitive Market Share Analysis |
| Non-Adherent Contact Layer Market |
| 12.1 Introduction |
| 12.2 Market Overview |
| 12.3 Market Analysis and Forecast |
| 12.3.1 Non-Adherent Contact Layer Market |
| 12.3.2 Hospital Non-Adherent Contact Layer Market |
| 12.3.3 Alternate Care Non-Adherent Contact Layer Market |
| 12.4 Drivers and Limiters |
| 12.4.1 Market Drivers |
| 12.4.2 Market Limiters |
| 12.5 Competitive Market Share Analysis |
| Surgical Hemostat Market |
| 13.1 Introduction |
| 13.1.1 Polysaccharide-Based Hemostats |
| 13.1.2 Oxidized Regenerated Cellulose-Based Hemostats |
| 13.1.3 Thrombin-Based Hemostats |
| 13.1.4 Gelatin-Based Hemostats |
| 13.1.5 Collagen-Based Hemostats |
| 13.1.6 Combination Hemostats |
| 13.1.7 First Responder Hemostats |
| 13.2 Market Overview |
| 13.3 Market Analysis and Forecast |
| 13.3.1 Surgical Hemostat Market |
| 13.3.2 Thrombin-Based Hemostat Market |
| 13.3.3 Oxidized Regenerated Cellulose Hemostat Market |
| 13.3.4 Gelatin-Based Hemostat Market |
| 13.3.5 Collagen-Based Hemostat Market |
| 13.3.6 Combination Hemostat Market |
| 13.3.7 Polysaccharide-Based Hemostat Market |
| 13.3.8 First Responder Hemostat Market |
| 13.4 Drivers and Limiters |
| 13.4.1 Market Drivers |
| 13.4.2 Market Limiters |
| 13.5 Competitive Market Share Analysis |
| Tissue Sealant Market |
| 14.1 Introduction |
| 14.1.1 Fibrin Sealants |
| 14.1.2 Protein-Based Sealants |
| 14.1.3 Synthetic Tissue Sealants |
| 14.2 Market Overview |
| 14.3 Market Analysis and Forecast |
| 14.3.1 Tissue Sealant Market |
| 14.3.2 Fibrin-Based Tissue Sealant Market |
| 14.3.3 Protein-Based Tissue Sealant Market |
| 14.3.4 Synthetic Tissue Sealant Market |
| 14.4 Drivers and Limiters |
| 14.4.1 Market Drivers |
| 14.4.2 Market Limiters |
| 14.5 Competitive Market Share Analysis |
| Anti-Adhesion Market |
| 15.1 Introduction |
| 15.2 Market Overview |
| 15.3 Market Analysis and Forecast |
| 15.3.1 Anti-Adhesion Market |
| 15.3.2 Gynecological Procedure Market |
| 15.3.3 Abdominal Procedure Market |
| 15.3.4 Other Procedure Market |
| 15.4 Drivers and Limiters |
| 15.4.1 Market Drivers |
| 15.4.2 Market Limiters |
| 15.5 Competitive Market Share Analysis |
| Negative Pressure Wound Therapy Market |
| 16.1 Introduction |
| 16.2 Market Overview |
| 16.3 Market Analysis and Forecast |
| 16.3.1 Single-Use NPWT Pump Market |
| 16.3.1.1 Hospital Single-Use NPWT Pump Market |
| 16.3.1.2 Alternate Care Single-Use NPWT Pump Market |
| 16.3.2 Conventional NPWT Pump Rental Market |
| 16.3.2.1 Hospital Conventional NPWT Pump Rental Market |
| 16.3.2.2 Alternate Care Conventional NPWT Pump Rental Market |
| 16.3.3 NPWT Dressing Market |
| 16.3.3.1 Hospital NPWT Dressing Market |
| 16.3.3.2 Alternate Care NPWT Dressing Market |
| 16.3.4 NPWT Canister Market |
| 16.3.4.1 Hospital NPWT Canister Market |
| 16.3.4.2 Alternate Care NPWT Canister Market |
| 16.4 Drivers and Limiters |
| 16.4.1 Market Drivers |
| 16.4.2 Market Limiters |
| 16.5 Competitive Market Share Analysis |
| Static Compression Therapy Market |
| 17.1 Introduction |
| 17.1.1 Graduated Compression Stockings |
| 17.1.2 Anti-Embolism Stockings |
| 17.1.3 Compression Bandages |
| 17.1.4 Unna Boot |
| 17.2 Market Overview |
| 17.3 Market Analysis and Forecast |
| 17.3.1 Graduated Compression Stocking Market |
| 17.3.1.1 OTC Graduated Compression Stocking Market |
| 17.3.1.2 Medical Grade Graduated Compression Stocking Market |
| 17.3.2 Anti-Embolism Stocking Market |
| 17.3.3 Compression Bandage Market |
| 17.3.3.1 Compression Kit Market |
| 17.3.3.2 Adhesive Bandage Market |
| 17.3.3.3 Cohesive Bandage Market |
| 17.3.4 Unna Boot Market |
| 17.4 Drivers and Limiters |
| 17.4.1 Market Drivers |
| 17.4.2 Market Limiters |
| 17.5 Competitive Market Share Analysis |
| Dynamic Compression Therapy Market |
| 18.1 Introduction |
| 18.1.1 Dynamic Deep Vein Thrombosis Prevention |
| 18.1.2 Mobile Deep Vein Thrombosis Compression |
| 18.1.3 Pneumatic Compression |
| 18.2 Market Overview |
| 18.3 Market Analysis and Forecast |
| 18.3.1 Dynamic DVT Prevention Device Market |
| 18.3.2 Mobile DVT Prevention Device Market |
| 18.3.3 Pneumatic Compression Device Market |
| 18.3.3.1 Sequential Compression Device Market |
| 18.3.3.1.1 Sequential Compression Pump Market |
| 18.3.3.1.2 Sequential Compression Sleeve Market |
| 18.3.3.2 Calibrated Sequential Compression Device Market |
| 18.3.3.2.1 Calibrated Sequential Compression Pump Market |
| 18.3.3.2.2 Calibrated Sequential Compression Sleeve Market |
| 18.4 Drivers and Limiters |
| 18.4.1 Market Drivers |
| 18.4.2 Market Limiters |
| 18.5 Competitive Market Share Analysis |
| Abbreviations |
Companies Included:
| · 3M | · ConvaTec |
| · Actamax | · Cooper Surgical |
| · Adhezion Biomedical | · Cryolife |
| · Advancis Medical | · DermaRite Industries |
| · Airway Surgical Appliances | · DeRoyal |
| · Allegro | · Drawtex |
| · Alliqua Biomedical | · Dukal Corp |
| · Allosource | · Dynarex Inc |
| · Ames Walker | · Elastic Therapy Inc. (DJO) |
| · Andover Healthcare | · Essity |
| · Anika Therapeutics | · Ethicon |
| · Appulse | · Ferris Mfg Corp |
| · Argentum Medical | · Frankenman |
| · Arjo | · FzioMed |
| · Arthrex | · Gentell |
| · Avita | · GluStitch |
| · Baxter | · Graham-Field |
| · Becton Dickinson | · HARTMANN |
| · Beiersdorf | · Hemcon |
| · Betatech Medical | · Hemostasis LLC |
| · Bio Compression Systems | · Hollister |
| · Cardinal Health | · Human Biosciences |
| · Celox | · Hyperbranch Medical |
| · Chemence | · Hyperice |
| · Cohera Medical | · Innocoll |
| · Coloplast | · Integra LifeSciences |
| · ConMed | · Intuitive Surgical |
| · Johnson & Johnson | · PolyNovo |
| · Juzo | · Precision medical |
| · Karl Storz | · Purple Surgical |
| · Kerecis | · Reach Surgical |
| · Kimberly Clark | · Reliamed |
| · Lohmann & Rauscher | · Robinson Healthcare |
| · Manamed | · Scion Biomedical |
| · Manuka Med | · SIGVARIS |
| · Marine Polymer Technologies | · SmartKnit |
| · Mast Biosurgery | · Smith & Nephew |
| · Mckesson | · Soluble Systems |
| · Medipurpose | · Stimlabs |
| · mediUSA | · Stryker |
| · Medline | · SunMedix |
| · Medlogic | · Surgical Specialties |
| · Medtronic | · Tactile Medical |
| · Merit Medical | · Teleflex |
| · Microline Surgical | · Therafirm |
| · MiMedx | · Tissue Regenix |
| · Mölnlycke | · URGO medical |
| · MPM Medical | · Venosan |
| · MTF Wound Care | · Vericell |
| · Ocular Therapeutix | · Xtant Medical |
| · Organogenesis | · Zimmer Biomet |
List of Charts
| Chart 1‑1: Wound and Tissue Management Market by Segment, U.S., 2021 – 2028 |
| Chart 1‑2: Wound and Tissue Management Market Overview, U.S., 2021 & 2028 |
| Chart 2‑1: Multi-Scenario Wound and Tissue Management Market Forecast, U.S., 2018 – 2028 (US$M) |
| Chart 5‑1: Wound and Tissue Management Market by Segment, U.S., 2018 – 2028 |
| Chart 5‑2: Leading Competitors, Wound and Tissue Management Market, U.S., 2021 |
| Chart 6‑1: Wound Closure Market by Segment, U.S., 2018 – 2028 |
| Chart 6‑2: Leading Competitors, Wound Closure Market, U.S., 2021 |
| Chart 7‑1: Traditional Wound Dressing Market by Segment, U.S., 2018 – 2028 |
| Chart 7‑2: Leading Competitors, Traditional Wound Dressing Market, U.S., 2021 |
| Chart 8‑1: Advanced Wound Dressing Market by Segment, U.S., 2018 – 2028 |
| Chart 8‑2: Leading Competitors, Advanced Wound Dressing Market, U.S., 2021 |
| Chart 9‑1: Moist Dressing Market by Segment, U.S., 2018 – 2028 |
| Chart 9‑2: Moist Dressing Market by Care Setting, U.S., 2018 – 2028 |
| Chart 9‑3: Leading Competitors, Moist Dressing Market, U.S., 2021 |
| Chart 10‑1: Antimicrobial Dressing Market by Segment, U.S., 2018 – 2028 |
| Chart 10‑2: Antimicrobial Dressing Market by Care Setting, U.S., 2018 – 2028 |
| Chart 10‑3: Leading Competitors, Antimicrobial Dressing Market, U.S., 2021 |
| Chart 11‑1: Interactive Dressing Market by Segment, U.S., 2018 – 2028 |
| Chart 11‑2: Leading Competitors, Interactive Dressing Market, U.S., 2021 |
| Chart 12‑1: Non-Adherent Contact Layer Market by Segment, U.S., 2018 – 2028 |
| Chart 12‑2: Leading Competitors, Non-Adherent Contact Layer Market, U.S., 2021 |
| Chart 13‑1: Surgical Hemostat Market by Segment, U.S., 2018 – 2028 |
| Chart 13‑2: Leading Competitors, Surgical Hemostat Market, U.S., 2021 |
| Chart 14‑1: Tissue Sealant Market by Segment, U.S., 2018 – 2028 |
| Chart 14‑2: Leading Competitors, Tissue Sealant Market, U.S., 2021 |
| Chart 15‑1: Anti-Adhesion Market by Application, U.S., 2018 – 2028 |
| Chart 15‑2: Leading Competitors, Anti-Adhesion Market, U.S., 2021 |
| Chart 16‑1: Negative Pressure Wound Therapy Market by Segment, U.S., 2018 – 2028 |
| Chart 16‑2: Leading Competitors, Negative Pressure Wound Therapy Market, U.S., 2021 |
| Chart 17‑1: Static Compression Therapy Market by Segment, U.S., 2018 – 2028 |
| Chart 17‑2: Leading Competitors, Static Compression Therapy Market, U.S., 2021 |
| Chart 18‑1: Dynamic Compression Therapy Market by Segment, U.S., 2018 – 2028 |
| Chart 18‑2: Leading Competitors, Dynamic Compression Therapy Market, U.S., 2021 |
List of Figures
| Figure 1‑1: Wound and Tissue Management Market Share Ranking by Segment, U.S., 2021 (1 of 2) |
| Figure 1‑2: Wound and Tissue Management Market Share Ranking by Segment, U.S., 2021 (2 of 2) |
| Figure 1‑3: Companies Researched in this Report (1 of 2) |
| Figure 1‑4: Companies Researched in this Report (2 of 2) |
| Figure 1‑5: Factors Impacting the Wound and Tissue Management Market by Segment, U.S. (1 of 2) |
| Figure 1‑6: Factors Impacting the Wound and Tissue Management Market by Segment, U.S. (2 of 2) |
| Figure 1‑7: Recent Events in the Wound and Tissue Management Market, U.S., 2018 – 2021 |
| Figure 1‑8: Wound and Tissue Management Markets Covered (1 of 5) |
| Figure 1‑9: Wound and Tissue Management Markets Covered (2 of 5) |
| Figure 1‑10: Wound and Tissue Management Markets Covered (3 of 5) |
| Figure 1‑11: Wound and Tissue Management Markets Covered (4 of 5) |
| Figure 1‑12: Wound and Tissue Management Markets Covered (5 of 5) |
| Figure 1‑13: Key Report Updates |
| Figure 1‑14: Version History |
| Figure 2‑1: Wound and Tissue Management Market by Segment, Worst Case Scenario, U.S., 2018 – 2028 (US$M) (1 of 2) |
| Figure 2‑2: Wound and Tissue Management Market by Segment, Worst Case Scenario, U.S., 2018 – 2028 (US$M) (2 of 2) |
| Figure 2‑3: Wound and Tissue Management Market by Segment, Base Case Scenario, U.S., 2018 – 2028 (US$M) (1 of 2) |
| Figure 2‑4: Wound and Tissue Management Market by Segment, Base Case Scenario, U.S., 2018 – 2028 (US$M) (2 of 2) |
| Figure 2‑5: Wound and Tissue Management Market by Segment, Best Case Scenario, U.S., 2018 – 2028 (US$M) (1 of 2) |
| Figure 2‑6: Wound and Tissue Management Market by Segment, Best Case Scenario, U.S., 2018 – 2028 (US$M) (2 of 2) |
| Figure 4‑1 Wound Closure Device Products by Company (1 of 2) |
| Figure 4‑2 Wound Closure Device Market by Company (2 of 2) |
| Figure 4‑3 Traditional Wound Dressing Market by Company (1 of 2) |
| Figure 4‑4 Traditional Wound Dressings by Company (2 of 2) |
| Figure 4‑5: Advanced Wound Dressings Market by Company (1 of 6) |
| Figure 4‑6: Advanced Wound Dressings Market by Company (2 of 6) |
| Figure 4‑7: Advanced Wound Dressings Market by Company (3 of 6) |
| Figure 4‑8: Advanced Wound Dressings Market by Company (4 of 6) |
| Figure 4‑9: Advanced Wound Dressings Market by Company (5 of 6) |
| Figure 4‑10: Advanced Wound Dressings Market by Company (6 of 6) |
| Figure 4‑11 Surgical Hemostat Market by Company |
| Figure 4‑12 Tissue Sealant Products by Company |
| Figure 4‑13: Anti-Adhesion Market by Company |
| Figure 4‑14: Negative Pressure Wound Therapy Products by Company |
| Figure 4‑15: Static Compression Theraply by Company (1 of 3) |
| Figure 4‑16: Static Compression Theraply by Company (2 of 3) |
| Figure 4‑17: Static Compression Theraply by Company (3 of 3) |
| Figure 4‑18: Dynamic Compression Therapy by Company (1 of 2) |
| Figure 4‑19: Dynamic Compression Therapy by Company (2 of 2) |
| Figure 4‑20: Class 2 Device Recall Class 2 Device Recall Ethicon ECHELON FLEX Powered Plus Stapler |
| Figure 4‑21: Class 2 Class 2 Class 2 Device Recall VICRYL MONOFILAMENT VIOLET |
| Figure 4‑22: Class 2 Device Recall: MERSILK and PERMAHAND, Braided Silk and Virgin Silk Non-Absorbable Suture |
| Figure 4‑23: Class 2 Device Recall |
| Figure 4‑24: Class 2 Device Recall Ethicon Dermabond Advanced Topical Skin Adhesive-topical skin adhesive |
| Figure 4‑25: Class 2 Class 2 Device Recall Ethicon Surgical, absorbable, polydioxanone Sutures |
| Figure 4‑26:Class 2 Device Recall Ethicon Absorbable, synthetic, polyglycolic acid Sutures |
| Figure 4‑27: Class 2 Device Recall Velosorb Fast Braided Absorbable Suture |
| Figure 4‑28: Class 2 Device Recall: Figure 4‑29: Class 2 Device Recall Velosorb Fast Braided Absorbable Suture |
| Figure 4‑30: Class 2 Device Recall Endo GIA Auto Suture Universal Articulating Loading |
| Figure 4‑31: Cesarean Wound Closure: Dermabond Versus Steri Strips |
| Figure 4‑32: Negative Pressure Wound Therapy in Diabetic Wounds |
| Figure 4‑33: Does PREVENA Vacuum-assisted Closure Reduce Lymphorrhoea Compared to Conventional Wound Closure After Axillary and Inguinal Lymph Node Dissection in the Management of Metastatic Cutaneous Skin Tumors? |
| Figure 4‑34: A Phase III Randomized Controlled Trial of Negative Pressure Wound Therapy in Post-Operative Incision Management |
| Figure 4‑35: A Pilot Study to Compare the Efficacy of NPWT PRO Versus KCI Ulta® NPWT and to Compare NPWT PRO Versus NPWT PRO With Simultaneous Irrigation on Wound Healing |
| Figure 4‑36: Vicryl Rapide Versus Nonabsorbable Suture in Repair of Simple Traumatic Extremity and Trunk Lacerations in Adult Patients |
| Figure 4‑37: Barbed Suture: A Look at Its Use for Hysterotomy Closure During Cesarean Section |
| Figure 4‑38: Subcuticular Absorbable Staples Versus Conventional Skin Closure in Women Undergoing Cesarean Delivery: A Randomized Control Trial |
| Figure 4‑39: An Adaptive, Randomized, Controlled Trial Evaluating the Effectiveness of PermeaDerm® (PD) as Compared to Mepilex Ag® Used as Standard of Care in the Treatment of Adult and Pediatric Partial Thickness Burns. |
| Figure 4‑40: Efficacy of Negative Pressure Wound Closure Therapy by PICO System in Prevention of Complications of Femoral Artery Exposure |
| Figure 4‑41: PICO Negative Pressure Wound Therapy in Obese Women Undergoing Elective Cesarean Delivery. |
| Figure 4‑42The Effect of Negative Pressure Wound Therapy on Wound Healing in Major Amputations |
| Figure 4‑43: Effect of Negative Pressure Wound Therapy After Surgical Removal of Deep-Seated High-Malignant Soft Tissue Sarcomas of the Extremities and Trunk Wall. |
| Figure 5‑1: Wound and Tissue Management Market by Segment, U.S., 2018 – 2028 (US$M) (1 of 2) |
| Figure 5‑2: Wound and Tissue Management Market by Segment, U.S., 2018 – 2028 (US$M) (2 of 2) |
| Figure 5‑3: Leading Competitors, Wound and Tissue Management Market, U.S., 2021 (1 of 2) |
| Figure 5‑4: Leading Competitors, Wound and Tissue Management Market, U.S., 2021 (2 of 2) |
| Figure 5‑5: SWOT Analysis, 3M (1 of 2) |
| Figure 5‑6: SWOT Analysis, 3M (2 of 2) |
| Figure 5‑7: SWOT Analysis, Baxter |
| Figure 5‑8: SWOT Analysis, Essity (1 of 2) |
| Figure 5‑9: SWOT Analysis, Essity (2 of 2) |
| Figure 5‑10: SWOT Analysis Becton Dickinson (1 of 2) |
| Figure 5‑11: SWOT Analysis Becton Dickinson (2 of 2) |
| Figure 5‑12: SWOT Analysis Cardinal Health (1 of 2) |
| Figure 5‑13: SWOT Analysis Cardinal Health (2 of 2) |
| Figure 5‑14: SWOT Analysis, CryoLife |
| Figure 5‑15: SWOT Analysis, Ethicon, 2021 (1 of 2) |
| Figure 5‑16: SWOT Analysis, Ethicon (2 of 2) |
| Figure 5‑17: SWOT Analysis, Medline (1 of 2) |
| Figure 5‑18: SWOT Analysis, Medline (1 of 2) |
| Figure 5‑19: SWOT Analysis, Medtronic (1 of 2) |
| Figure 5‑20: SWOT Analysis, Medtronic (2 of 2) |
| Figure 5‑21: SWOT Analysis, MiMedx |
| Figure 5‑22: SWOT Analysis, Mölnlycke |
| Figure 5‑23: SWOT Analysis, Pfizer (1 of 2) |
| Figure 5‑24: SWOT Analysis, Pfizer (2 of 2) |
| Figure 5‑25: SWOT Analysis, Smith & Nephew (1 of 2) |
| Figure 5‑26: SWOT Analysis, Smith & Nephew (2 of 2) |
| Figure 6‑1: Wound Closure Market by Segment, U.S., 2018 – 2028 (US$M) (1 of 2) |
| Figure 6‑2: Wound Closure Market by Segment, U.S., 2018 – 2028 (US$M) (2 of 2) |
| Figure 6‑3: Total Suture Market, U.S., 2018 – 2028 |
| Figure 6‑4: Suture Market by Device Type, U.S., 2018 – 2028 (US$M) |
| Figure 6‑5: Absorbable Suture Market, U.S., 2018 – 2028 |
| Figure 6‑6: Non-Absorbable Suture Market, U.S., 2018 – 2028 |
| Figure 6‑7: Knotless Tissue Closure Market, U.S., 2018 – 2028 |
| Figure 6‑8: Suture Market by Infection Control Type, U.S., 2018 – 2028 (US$M) |
| Figure 6‑9: Antibacterial Suture Market, U.S., 2018 – 2028 |
| Figure 6‑10: Standard Suture Market, U.S., 2018 – 2028 |
| Figure 6‑11: Suture Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 6‑12: Hospital Suture Market, U.S., 2018 – 2028 |
| Figure 6‑13: Alternate Care Suture Market, U.S., 2018 – 2028 |
| Figure 6‑14: Stapler Market by Device Type, U.S., 2018 – 2028 (US$M) |
| Figure 6‑15: Open Surgery Stapler by Segment Market, U.S., 2018 – 2028 |
| Figure 6‑16: Open Surgery Firing Gun Market, U.S., 2018 – 2028 |
| Figure 6‑17: Open Surgery Cartridge Market, U.S., 2018 – 2028 |
| Figure 6‑18: Laparoscopic Stapler by Segment Market, U.S., 2018 – 2028 |
| Figure 6‑19: Laparoscopic Firing Gun Market, U.S., 2018 – 2028 |
| Figure 6‑20: Laparoscopic Cartridge Market, U.S., 2018 – 2028 |
| Figure 6‑21: Skin Stapler Market, U.S., 2018 – 2028 |
| Figure 6‑22: Stapler Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 6‑23: Hospital Stapler Market, U.S., 2018 – 2028 |
| Figure 6‑24: Alternate Care Stapler Market, U.S., 2018 – 2028 |
| Figure 6‑25: Ligating Clip Applier Market by Device Type, U.S., 2018 – 2028 (US$M) |
| Figure 6‑26: Open Surgery Ligation by Segment Market, U.S., 2018 – 2028 |
| Figure 6‑27: Open Surgery Multi-Fire Clip Applier Market, U.S., 2018 – 2028 |
| Figure 6‑28: Open Surgery Single-Fire Clip Applier Market, U.S., 2018 – 2028 |
| Figure 6‑29: Laparoscopic Ligation by Segment Market, U.S., 2018 – 2028 |
| Figure 6‑30: Laparoscopic Multi-Fire Clip Applier Market, U.S., 2018 – 2028 |
| Figure 6‑31: Laparoscopic Single-Fire Clip Applier Market, U.S., 2018 – 2028 |
| Figure 6‑32: Ligation Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 6‑33: Hospital Ligation Market, U.S., 2018 – 2028 |
| Figure 6‑34: Alternate Care Ligation Market, U.S., 2018 – 2028 |
| Figure 6‑35: Skin Closure Strip Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 6‑36: Total Skin Closure Strip Market, U.S., 2018 – 2028 |
| Figure 6‑37: Hospital Skin Closure Strip Market, U.S., 2018 – 2028 |
| Figure 6‑38: Alternate Care Skin Closure Strip Market, U.S., 2018 – 2028 |
| Figure 6‑39: Total Mesh and Cyanoacrylate-Based Skin Closure System Market, U.S., 2018 – 2028 |
| Figure 6‑40: Total Zip Surgical Skin Closure Market, U.S., 2018 – 2028 |
| Figure 6‑41: Cyanoacrylate-Based Tissue Adhesive Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 6‑42: Total Cyanoacrylate-Based Tissue Adhesive Market, U.S., 2018 – 2028 |
| Figure 6‑43: Hospital Cyanoacrylate-Based Tissue Adhesive Market, U.S., 2018 – 2028 |
| Figure 6‑44: Alternate Care Cyanoacrylate-Based Tissue Adhesive Market, U.S., 2018 – 2028 |
| Figure 6‑45: Leading Competitors, Wound Closure Market, U.S., 2021 (1 of 2) |
| Figure 6‑46: Leading Competitors, Wound Closure Market, U.S., 2021 (2 of 2) |
| Figure 7‑1: Traditional Wound Dressing Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 7‑2: Gauze Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 7‑3: Total Gauze Market, U.S., 2018 – 2028 |
| Figure 7‑4: Hospital Gauze Market, U.S., 2018 – 2028 |
| Figure 7‑5: Alternate Care Gauze Market, U.S., 2018 – 2028 |
| Figure 7‑6: Tape Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 7‑7: Total Tape Market, U.S., 2018 – 2028 |
| Figure 7‑8: Hospital Tape Market, U.S., 2018 – 2028 |
| Figure 7‑9: Alternate Care Tape Market, U.S., 2018 – 2028 |
| Figure 7‑10: Bandage Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 7‑11: Total Bandage Market, U.S., 2018 – 2028 |
| Figure 7‑12: Hospital Bandage Market, U.S., 2018 – 2028 |
| Figure 7‑13: Alternate Care Bandage Market, U.S., 2018 – 2028 |
| Figure 7‑14: Cotton Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 7‑15: Total Cotton Market, U.S., 2018 – 2028 |
| Figure 7‑16: Hospital Cotton Market, U.S., 2018 – 2028 |
| Figure 7‑17: Alternate Care Cotton Market, U.S., 2018 – 2028 |
| Figure 7‑18: Leading Competitors, Traditional Wound Dressing Market, U.S., 2021 |
| Figure 8‑1: Advanced Wound Dressing Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 8‑2: Leading Competitors, Advanced Wound Dressing Market, U.S., 2021 |
| Figure 9‑1: Moist Dressing Market by Segment, U.S., 2018 – 2028 (US$M) (1 of 2) |
| Figure 9‑2: Moist Dressing Market by Segment, U.S., 2018 – 2028 (US$M) (2 of 2) |
| Figure 9‑3: Moist Dressing Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 9‑4: Moist Dressing Market, U.S., 2018 – 2028 |
| Figure 9‑5: Foam Dressing Market, U.S., 2018 – 2028 |
| Figure 9‑6: Transparent Film Dressing Market, U.S., 2018 – 2028 |
| Figure 9‑7: Hydrocolloid Dressing Market, U.S., 2018 – 2028 |
| Figure 9‑8: Alginate Dressing Market, U.S., 2018 – 2028 |
| Figure 9‑9: Gelling Fiber Dressing Market, U.S., 2018 – 2028 |
| Figure 9‑10: Hydrogel Dressing Market, U.S., 2018 – 2028 |
| Figure 9‑11: Hospital Moist Dressing Market, U.S., 2018 – 2028 |
| Figure 9‑12: Alternate Care Moist Dressing Market, U.S., 2018 – 2028 |
| Figure 9‑13: Leading Competitors, Moist Dressing Market, U.S., 2021 |
| Figure 10‑1: Antimicrobial Dressing Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 10‑2: Antimicrobial Dressing Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 10‑3: Antimicrobial Dressing Market, U.S., 2018 – 2028 |
| Figure 10‑4: Silver Dressing Market, U.S., 2018 – 2028 |
| Figure 10‑5: Non-Silver Dressing Market, U.S., 2018 – 2028 |
| Figure 10‑6: Hospital Antimicrobial Dressing Market, U.S., 2018 – 2028 |
| Figure 10‑7: Alternate Care Antimicrobial Dressing Market, U.S., 2018 – 2028 |
| Figure 10‑8: Leading Competitors, Antimicrobial Dressing Market, U.S., 2021 |
| Figure 11‑1: Interactive Dressing Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 11‑2: Collagen Dressing Market, U.S., 2018 – 2028 |
| Figure 11‑3: Skin Substitute Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 11‑4: Total Skin Substitute Market, U.S., 2018 – 2028 |
| Figure 11‑5: Particulate Skin Substitute Market, U.S., 2018 – 2028 |
| Figure 11‑6: Sheet Skin Substitute Market, U.S., 2018 – 2028 |
| Figure 11‑7: Other Substitute Market, U.S., 2018 – 2028 |
| Figure 11‑8: Hospital Skin Substitute Market, U.S., 2018 – 2028 |
| Figure 11‑9: Alternate Care Skin Substitute Market, U.S., 2018 – 2028 |
| Figure 11‑10: Leading Competitors, Interactive Dressing Market, U.S., 2021 |
| Figure 12‑1: Non-Adherent Contact Layer Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 12‑2: Non-Adherent Contact Layer Market, U.S., 2018 – 2028 |
| Figure 12‑3: Hospital Non-Adherent Contact Layer Market, U.S., 2018 – 2028 |
| Figure 12‑4: Alternate Care Non-Adherent Contact Layer Market, U.S., 2018 – 2028 |
| Figure 12‑5: Leading Competitors, Non-Adherent Contact Layer Market, U.S., 2021 |
| Figure 13‑1: Surgical Hemostat Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 13‑2: Surgical Hemostat Market, U.S., 2018 – 2028 |
| Figure 13‑3: Thrombin-Based Hemostat Market, U.S., 2018 – 2028 |
| Figure 13‑4: Oxidized Regenerated Cellulose Hemostat Market, U.S., 2018 – 2028 |
| Figure 13‑5: Gelatin-Based Hemostat Market, U.S., 2018 – 2028 |
| Figure 13‑6: Collagen-Based Hemostat Market, U.S., 2018 – 2028 |
| Figure 13‑7: Combination Hemostat Market, U.S., 2018 – 2028 |
| Figure 13‑8: Polysaccharide-Based Hemostat Market, U.S., 2018 – 2028 |
| Figure 13‑9: First Responder Hemostat Market, U.S., 2018 – 2028 |
| Figure 13‑10: Leading Competitors, Surgical Hemostat Market, U.S., 2021 (1 of 2) |
| Figure 13‑11: Leading Competitors, Surgical Hemostat Market, U.S., 2021 (2 of 2) |
| Figure 14‑1: Tissue Sealant Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 14‑2: Tissue Sealant Market, U.S., 2018 – 2028 |
| Figure 14‑3: Fibrin-Based Tissue Sealant Market, U.S., 2018 – 2028 |
| Figure 14‑4: Protein-Based Tissue Sealant Market, U.S., 2018 – 2028 |
| Figure 14‑5: Synthetic Tissue Sealant Market, U.S., 2018 – 2028 |
| Figure 14‑6: Leading Competitors, Tissue Sealant Market, U.S., 2021 |
| Figure 15‑1: Anti-Adhesion Market by Application, U.S., 2018 – 2028 (US$M) |
| Figure 15‑2: Anti-Adhesion Market, U.S., 2018 – 2028 |
| Figure 15‑3: Gynecological Procedure Market, U.S., 2018 – 2028 |
| Figure 15‑4: Abdominal Procedure Market, U.S., 2018 – 2028 |
| Figure 15‑5: Other Procedure Market, U.S., 2018 – 2028 |
| Figure 15‑6: Leading Competitors, Anti-Adhesion Market, U.S., 2021 |
| Figure 16‑1: Negative Pressure Wound Therapy Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 16‑2: Single-Use NPWT Pump Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 16‑3: Total Single-Use NPWT Pump Market, U.S., 2018 – 2028 |
| Figure 16‑4: Hospital Single-Use NPWT Pump Market, U.S., 2018 – 2028 |
| Figure 16‑5: Alternate Care Single-Use NPWT Pump Market, U.S., 2018 – 2028 |
| Figure 16‑6: Conventional NPWT Pump Rental Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 16‑7: Total Conventional NPWT Pump Rental Market, U.S., 2018 – 2028 |
| Figure 16‑8: Hospital Conventional NPWT Pump Rental Market, U.S., 2018 – 2028 |
| Figure 16‑9: Alternate Care Conventional NPWT Pump Rental Market, U.S., 2018 – 2028 |
| Figure 16‑10: NPWT Dressing Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 16‑11: Total NPWT Dressing Market, U.S., 2018 – 2028 |
| Figure 16‑12: Hospital NPWT Dressing Market, U.S., 2018 – 2028 |
| Figure 16‑13: Alternate Care NPWT Dressing Market, U.S., 2018 – 2028 |
| Figure 16‑14: NPWT Canister Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 16‑15: Total NPWT Canister Market, U.S., 2018 – 2028 |
| Figure 16‑16: Hospital NPWT Canister Market, U.S., 2018 – 2028 |
| Figure 16‑17: Alternate Care NPWT Canister Market, U.S., 2018 – 2028 |
| Figure 16‑18: Leading Competitors, Negative Pressure Wound Therapy Market, U.S., 2021 |
| Figure 17‑1: Static Compression Therapy Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 17‑2: Graduated Compression Stocking Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 17‑3: Total Graduated Compression Stocking Market, U.S., 2018 – 2028 |
| Figure 17‑4: OTC Graduated Compression Stocking Market, U.S., 2018 – 2028 |
| Figure 17‑5: Medical Grade Graduated Compression Stocking Market, U.S., 2018 – 2028 |
| Figure 17‑6: Anti-Embolism Stocking Market, U.S., 2018 – 2028 |
| Figure 17‑7: Compression Bandage Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 17‑8: Total Compression Bandage Market, U.S., 2018 – 2028 |
| Figure 17‑9: Compression Kit Market, U.S., 2018 – 2028 |
| Figure 17‑10: Adhesive Bandage Market, U.S., 2018 – 2028 |
| Figure 17‑11: Cohesive Bandage Market, U.S., 2018 – 2028 |
| Figure 17‑12: Unna Boot Market, U.S., 2018 – 2028 |
| Figure 17‑13: Leading Competitors, Static Compression Therapy Market, U.S., 2021 |
| Figure 18‑1: Dynamic Compression Therapy Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 18‑2: Dynamic DVT Prevention Device Market, U.S., 2018 – 2028 |
| Figure 18‑3: Mobile DVT Prevention Device Market, U.S., 2018 – 2028 |
| Figure 18‑4: Pneumatic Compression Device Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 18‑5: Sequential Compression Device Market by Segment, U.S., 2018 – 2028 |
| Figure 18‑6: Sequential Compression Pump Market, U.S., 2018 – 2028 |
| Figure 18‑7: Sequential Compression Sleeve Market, U.S., 2018 – 2028 |
| Figure 18‑8: Calibrated Sequential Compression Device Market by Segment, U.S., 2018 – 2028 |
| Figure 18‑9: Calibrated Sequential Compression Pump Market, U.S., 2018 – 2028 |
| Figure 18‑10: Calibrated Sequential Compression Sleeve Market, U.S., 2018 – 2028 |
| Figure 18‑11: Leading Competitors, Dynamic Compression Therapy Market, U.S., 2021 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Wound and Tissue Management Market Size, Share, and COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Wound Closure Market, Anti-adhesion Market, and 11 more
$7,995 – $9,995
The full report suite on the U.S. market for wound and tissue management includes wound closure devices; traditional, moist, antimicrobial, interactive wound dressings; non-adherent contact layers; hemostats; tissue sealants; anti-adhesion; negative pressure wound therapy; and static and dynamic compression therapy.
- 2022
- 10 Years
- United States
- MedSuite
- 499
- 03/11/2022
Related Reports
